Positron Stock-Based Compensation 2010-2024 | POSC
Positron stock-based compensation from 2010 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| Positron Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $N/A |
| 2022 | $1 |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2014 | $0 |
| 2013 | $1 |
| 2012 | $2 |
| 2011 | $N/A |
| 2010 | $3 |
| 2009 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.050B | $0.001B |
| Positron Corporation is engaged in designing, manufacturing, marketing and supporting advanced medical imaging devices utilizing positron emissiontomography technology under the trade name POSICAM systems. POSICAM systems incorporate patented and proprietary technology for the diagnosis and treatment of patients in the areas of oncology, cardiology and neurology. | |||